Insider Transaction: David Quigley Granted Stock Options in CervoMed Inc.

David Quigley, a director at CervoMed Inc., was granted a stock option to purchase 8,150 shares of the company's common stock on June 8, 2026. This grant, made under the 2025 Equity Incentive Plan, is part of the non-employee director compensation policy. The option has an exercise price of $2.91 and an expiration date of June 8, 2036. The shares underlying the option will vest monthly over one year, starting June 30, 2026, contingent upon Quigley's continued service. This transaction is reported on Form 4.